Patient expectations and shared decision making in aRCC

3 year follow-up shows durable long-term RFS and DMFS benefit with mRNA-4157 plus pembrolizumab in resected melanoma

PD-1–refractory advanced melanoma: how do we get to the finish line?

Highlights in melanoma from ASCO 2024

Immunotherapy significantly increases the number of patients free from bowel cancer

Encouraging results using mismatched unrelated donors in stem cell transplantation

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

Dr Enrique Soto Pérez de Celis, new Editor-in-Chief ecancermedicalscience

Importance of MRD in newly developed multiple myeloma

Best practice in HRRm testing in patients with metastatic prostate cancer

Cancer advocacy and fundraising in Nigeria